# Keiretsu Forum Northwest

> Keiretsu Forum Northwest is a VC fund backing Health Care and Software. See 111 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Seattle, United States
- Total investments: 111
- Last investment: Aug 2022
- Lead investor: 5%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/keiretsu-forum-northwest/about/
- X (Twitter): http://twitter.com/k4northwest
- Website: http://k4northwest.com
- Facebook: https://www.facebook.com/keiretsuforum

Keiretsu Forum Northwest is a VC fund in Seattle focused on Health Care and Software. Keiretsu Forum is a community of private equity investors, business leaders and entrepreneurs with a network of over 50 global chapters and more than 2,500 investor members.

## Contacts

5 contacts available for Keiretsu Forum Northwest. Shizune tracks 8 team members at Keiretsu Forum Northwest. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/keiretsu-forum-northwest?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $507k–$3M |
| Series A | $600k–$8M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 26 | 23% |
| Software | 17 | 15% |
| Biotechnology | 15 | 14% |
| Manufacturing | 11 | 10% |
| Medical Device | 11 | 10% |

155 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 45 | 41% |
| Seed | 27 | 24% |
| Funding Round | 22 | 20% |
| Series B | 7 | 6% |
| Convertible Note | 4 | 4% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 80 | 72% |
| Spain | 8 | 7% |
| Canada | 5 | 5% |
| Israel | 5 | 5% |
| India | 2 | 2% |

8 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Don Megrath | Portland OR Chapter Co-President | 0 | https://shizune.co/investors/profile/don-megrath |
| Juan Arango | Entrepreneur Director | 0 | https://shizune.co/investors/profile/juan-arango |
| Loren Lyon | Bellevue/Eastside Chapter President | 0 | https://shizune.co/investors/profile/loren-lyon |
| Matthew Housser | Member | 0 | https://shizune.co/investors/profile/matthew-housser |
| Michael Volker | Vancouver BC Chapter Co-President | 2 | https://shizune.co/investors/profile/michael-volker |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| iQure Pharma | iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new therapeutics. | $600K | Series A | Aug 30, 2022 |  |
| Vartega | Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds. |  | Seed | Dec 01, 2021 |  |
| Levered Learning | Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States. | $1.5M |  | Oct 07, 2021 |  |
| Levered Learning | Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States. | $1.5M | Seed | Oct 07, 2021 |  |
| Inmedix | Inmedix has discovered and is commercializing a novel class of diagnostics and therapeutics. Their approach focuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. They call it Immuno-autonomics. They seek tounderstand and block this process to allow current autoimmune disease therapies to work much better. | $2.7M | Angel | Jan 01, 2019 |  |
| Vita Inclinata Technologies | Vita is an aerospace company that builds autonomous systems for helicopter hoisting and sling load missions. | $1.2M | Seed | Sep 30, 2018 |  |
| SageMedic | SageMedic develops a genome-free SAGE Direct Platform that introduces the next generation of precision medicine by directly testing effective cancer treatments on a live tissue biopsy of a patient. |  |  | Aug 29, 2018 |  |
| SageMedic | SageMedic develops a genome-free SAGE Direct Platform that introduces the next generation of precision medicine by directly testing effective cancer treatments on a live tissue biopsy of a patient. |  | Convertible Note | Aug 29, 2018 |  |
| CleanFiber | CleanFiber is a construction manufacturing company that makes building insulation from recycled corrugated cardboard. They are preparing to launch their first facility and they have customer commitments. The company was founded in 2013 and headquartered in Buffalo, New York. | $5M |  | Mar 27, 2018 |  |
| Novuson Surgical | Novuson, a spinout from the University of Washington’s highly regarded Applied Physics Laboratory’s Center for Industrial and Medical Ultrasound, is developing its Direct Therapeutic Ultrasound (DTU) technology platform for coagulation and hemostatic control in surgical and trauma procedures. DTU technology should enable clinicians to performsurgeries more quickly and to rapidly control bleeding associated with traumatic injuries. The company founders are Stuart B. Mitchell, PhD. and Francesco P. Curra, Ph.D.Novuson creates tools that reduce operational cost and operating time, eliminating bleeding complications and enhancing patient outcomes. These automatic devices use direct therapeutic ultrasound energy for fast and robust hemostasis, cauterization and division. The devices cauterize tissue from the inside out, creating a well-defined, controlled plane of cauterization. The company was founded in 2014 and based in Bothell, Washington. |  | Convertible Note | Oct 03, 2017 |  |

10 of 111 investments shown.

## Co-investors
- [Keiretsu Capital](https://shizune.co/investors/profile/keiretsu-capital) — VC Fund, 21 deals together
- [Alliance of Angels](https://shizune.co/investors/profile/alliance-of-angels) — VC Fund, 3 deals together
- [Keiretsu Forum Mid Atlantic](https://shizune.co/investors/profile/keiretsu-forum-mid-atlantic) — VC Fund, 3 deals together
- [Portland Seed Fund](https://shizune.co/investors/profile/portland-seed-fund) — VC Fund, 3 deals together
- [Rockies Venture Club](https://shizune.co/investors/profile/rockies-venture-club) — VC Fund, 3 deals together
- [American Family Insurance Institute for Corporate and Social Impact](https://shizune.co/investors/profile/amfam-institute-impact-fund) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [Proptech Investors in Canada](https://shizune.co/investors/proptech-investors-canada)
- [Sporting Goods VC Funds](https://shizune.co/investors/sporting-goods-vc-funds)
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)
- [Medical Device Investors in Israel](https://shizune.co/investors/medical-device-investors-israel)
- [Medical Device VC Funds in Israel](https://shizune.co/investors/medical-device-vc-funds-israel)

## FAQ

### What does Keiretsu Forum Northwest invest in?

Keiretsu Forum Northwest invests primarily in Health Care, Software and Biotechnology startups, most often at Series A and Seed stage. Most of the 111 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Keiretsu Forum Northwest's check size?

Keiretsu Forum Northwest typically joins rounds of $507k–$3M at Seed and $600k–$8M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Keiretsu Forum Northwest participates in.

### How do I contact Keiretsu Forum Northwest?

Public channels for Keiretsu Forum Northwest include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Keiretsu Forum Northwest?

The team at Keiretsu Forum Northwest includes Don Megrath (Portland OR Chapter Co-President), Juan Arango (Entrepreneur Director) and Loren Lyon (Bellevue/Eastside Chapter President), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co